Validation of the Endoscopic Part of the Spigelman Classification for Evaluating Duodenal Adenomatosis in Familial Adenomatous Polyposis: A Prospective Study of Interrater and Intrarater Reliability.
Journal
The American journal of gastroenterology
ISSN: 1572-0241
Titre abrégé: Am J Gastroenterol
Pays: United States
ID NLM: 0421030
Informations de publication
Date de publication:
01 02 2022
01 02 2022
Historique:
received:
19
05
2021
accepted:
27
10
2021
pubmed:
17
12
2021
medline:
23
2
2022
entrez:
16
12
2021
Statut:
ppublish
Résumé
In patients with familial adenomatous polyposis, the Spigelman classification is recommended for staging and risk stratification of duodenal adenomatosis. Although the classification has been used for decades, it has never been formally validated. We included consecutive FAP patients undergoing upper gastrointestinal endoscopic surveillance and evaluated the inter- and intrarater reliability of the Spigelman classification. The interrater reliability of the endoscopic parameters and the Spigelman classification was good and excellent, respectively. The intrarater reliability of the endoscopic parameters and the Spigelman classification was moderate and good, respectively. The results support continued use of the Spigelman classification as the primary end point for future studies and as key endoscopic performance measure.
Identifiants
pubmed: 34913876
doi: 10.14309/ajg.0000000000001582
pii: 00000434-202202000-00027
pmc: PMC8812431
doi:
Types de publication
Journal Article
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
343-345Informations de copyright
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.
Références
Ghorbanoghli Z, Bastiaansen BA, Langers AM, et al. Extracolonic cancer risk in Dutch patients with APC (adenomatous polyposis coli)-associated polyposis. J Med Genet 2018;55:11–4.
Karstensen JG, Burisch J, Pommergaard HC, et al. Colorectal cancer in individuals with familial adenomatous polyposis, based on analysis of the Danish polyposis registry. Clin Gastroenterol Hepatol 2019;17:2294–300.e1.
Spigelman AD, Williams CB, Talbot IC, et al. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989;2:783–5.
Groves CJ, Saunders BP, Spigelman AD, et al. Duodenal cancer in patients with familial adenomatous polyposis (FAP): Results of a 10 year prospective study. Gut 2002;50:636–41.
Bülow S, Björk J, Christensen IJ, et al. Duodenal adenomatosis in familial adenomatous polyposis. Gut 2004;53:381–6.
van Leerdam ME, Roos VH, van Hooft JE, et al. Endoscopic management of polyposis syndromes: European society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy 2019;51:877–95.
Kashiwagi H, Spigelman AD, Debinski HS, et al. Surveillance of ampullary adenomas in familial adenomatous polyposis. Lancet 1994;344:1582.
Thiruvengadam SS, Lopez R, O'Malley M, et al. Spigelman stage IV duodenal polyposis does not precede most duodenal cancer cases in patients with familial adenomatous polyposis. Gastrointest Endosc 2019;89:345–54.e2.
Latchford AR, Neale KF, Spigelman AD, et al. Features of duodenal cancer in patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol 2009;7:659–63.
Bonett DG. Sample size requirements for estimating intraclass correlations with desired precision. Stat Med 2002;21:1331–5.
Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 2016;15:155–63.
Portney LGWM. Foundations of Clinical Research: Applications to Practice. New Jersey: Prentice Hall. 2000.
Bülow S. Results of national registration of familial adenomatous polyposis. Gut 2003;52:742–6.